As a Free StocksGuide user, you can view scores for all 7,027 stocks worldwide.
7 Analysts have issued a Organovo Holdings, Inc. forecast:
7 Analysts have issued a Organovo Holdings, Inc. forecast:
Dec '24 |
+/-
%
|
||
Revenue | 0.12 0.12 |
52%
52%
|
|
Gross Profit | 0.09 0.09 |
-
|
|
EBITDA | -12 -12 |
37%
37%
|
EBIT (Operating Income) EBIT | -13 -13 |
37%
37%
|
Net Profit | -12 -12 |
35%
35%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Organovo Holdings, Inc. engages in the development of bioprinted human tissues that emulate human biology and disease. Its three-dimensional human tissue platform is enabled by its proprietary NovoGen Bioprinters and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company was founded on January 30, 2012 and is headquartered in San Diego, CA.
Head office | United States |
CEO | Keith Murphy |
Founded | 2012 |
Website | organovo.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.